Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression
This pooled analysis of data from 2 phase 3 trials of nivolumab therapy in treatment-naive patients with advanced melanoma assesses the safety and efficacy of continuing treatment beyond progression.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου